Associate Professor, Comprehensive Cancer Center, Yale University School of Medicine
Oncology
Dr. Stuart E. Seropian, MD
|
|
Give Review
Stuart E. Seropian, MD works in the field of Oncology. He graduated from George Washington University School of Medicine. George Washington University School of Medicine has a rank of 67 in research and a 0 in primary care He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Stuart Seropian is a published doctor as well. He has 26 publications published. The latest was: HLA-mismatched family donor transplants: a novel strategy as curative therapy for patients with hematologic disorders. Stuart Seropian accepts Medicare payments and is listed with Medicare.gov.
Publications
- The use of basiliximab-infliximab combination for the treatment of severe gastrointestinal Acute GvHD.
- Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell Lymphoma.
- Monitoring patient distress and related problems before and after Hematopoietic Stem Cell Transplantation.
- Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplant.
- Successful collection and enGraftment of autologous peripheral blood progenitor cells in poorly mobilized patients receiving high-dose granulocyte colony-stimulating f...
- Late afternoon dosing of plerixafor for stem Cell mobilization: a practical solution.
- Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.
- Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory Acute myeloid leukemia.
- Outpatient high-dose melphalan in multiple Myeloma patients.
- Lichen sclerosus and eosinophilic fasciitis as manifestations of Chronic graft-versus-host disease: expanding the sclerodermoid spectrum.
- Images in neuro-oncology. Large B-cell Lymphoma.
- A simplified approach to stem Cell mobilization in multiple myeloma patients not previously treated with alkylating agents.
- Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin''s Lymphoma.
- Isolation and flow cytometric analysis of T-Cell-depleted CD34+ PBPCs.
- Chronic graft-versus-host disease of the liver: presentation as an Acute hepatitis.
- Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem Cell transplantation.
- High-dose BEAM chemotherapy with autologous peripheral blood progenitor-Cell transplantation for unselected patients with primary refractory or relapsed Hodgkin''s dis...
- Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical s...
- Neutropenic infections in 100 patients with non-Hodgkin's Lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell t...
- HLA-mismatched family donor transplants: a novel strategy as curative therapy for patients with hematologic Disorders.
- Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV Disease following allogeneic bone marrow transplant.
- Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor Cell transplantation.
- Survey of attitudes of nurses working with AIDS patients.
- Prospective Evaluation of Acute Graft-Versus-Host Disease.
- Disseminated fusarium infection with muscle involvement.
Schools
George Washington University School of Medicine And Health Sciences
Yale New Haven Hospital
Yale New Haven HospYale University School Med
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Bladder Cancer
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Yale-New Haven Hospital -
George Washington University School of Medicine
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1871583328 | |
| NPPES Provider LastName | SEROPIAN | |
| NPPES Provider FirstName | STUART | |
| NPPES Provider ZIPCode | 065191369 | |
| NPPES Provider State | CT | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 187.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871583328 |
| Last Name Of The Provider | SEROPIAN |
| First Name Of The Provider | STUART |
| View All |
Similar Doctors
|
|
Dr. Daniel P. Petrylak, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Tara B. Sanft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jill Lacy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maysa M. Abu-Khalaf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diamando Psyrri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven D. Gore, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|